COMT and breast carcinoma: Similarly, in human breast cancer cells (MCF-7), 4-OHE2 treatment and inhibition of catechol-O-methyltransferase (COMT), the enzyme responsible for the breakdown of catechol estrogens into methoxyestradiol, induced γH2Ax expression in response to DNA damage [59].